We have invested over $200 million to support the treatment of kidney disease. Access grant opportunities, KDOQI Clinical Practice Guidelines, and clinical trial information.

Two researchers in a lab, looking at a sample through a microscope.
researcher lecturing

Grants & funding

Access information on NKF’s Research Grant Program, including available grants, funding cycle, eligibility requirements and application instructions.
abstract image showing connections between people

Kidney Research Connect

Sign up today to find patients and care partners to engage in your patient-centered outcomes research (PCOR) projects.

close up of medical lab

Research spotlight

See how NKF researchers are making strides in the fight against kidney disease.
Futuristic depiction of medical advancements for kidneys, alongside a doctor in a lab coat with gloves

NKF Innovation Fund

Learn about our game changing impact investment initiative aimed at fundamentally disrupting the fight against chronic kidney disease.

Mother and daughter focused between hands and smiling

Honor a Hero. Save a life.

On this special day of giving, we honor the many kidney community heroes leading the fight against kidney disease with acts of courage, compassion, support and hope. People like YOU powering NKF’s work and lifechanging progress for every loved one affected by kidney disease. Who will you honor?

KDOQI Clinical Practice Guidelines

World renown for improving the diagnosis and treatment of kidney disease, these guidelines have changed the practices of healthcare professionals and improved thousands of lives.

Clinical Trial Information for Patients

Learn more about how clinical trials can affect new treatment options in patients.
pills and tablets
Clinical studies in the United States are regulated by the Food and Drug Administration (FDA). Learn more about safety.
Interested in participating? Find clinical trials in your area.

Help Shape KDOQI

Help us identify future Kidney Disease Outcomes Quality Initiative controversies topics by completing this poll. We greatly appreciate your participation and welcome your feedback!